Please login to the form below

Not currently logged in
Email:
Password:

Prix Galien Awards

This page shows the latest Prix Galien Awards news and features for those working in and with pharma, biotech and healthcare.

Orphan drugs from Biogen and Amicus win UK Prix Galien

Orphan drugs from Biogen and Amicus win UK Prix Galien

Amicus receive their award from health minister Lord O'Shaughnessy. Sir Michael Rawlins, chairman of the MHRA and former NICE chairman was once again chairman of the Prix Galien awards, and ... However, as is frequently the case with products recognised

Latest news

  • Prix Galien opens for entries with new award Prix Galien opens for entries with new award

    2018 programme will include new medical technology category. Entries have opened for the 2018 UK Prix Galien Awards. ... Previous UK Prix Galien winners include well-known brands such as Viagra, Herceptin, Glivec, Xolair, Bexero, Cervarix and Gardasil.

  • AZ, BMS and Boehringer among UK Prix Galien finalists AZ, BMS and Boehringer among UK Prix Galien finalists

    AstraZeneca, Bristol-Myers Squibb and Boehringer Ingelheim are among the finalists for the 2016 UK Prix Galien Awards. ... Entry to the latter is only open to medicines that have previously won or received a commendation at the UK Prix Galien Awards, and

  • Pharma could make more of its real world evidence Pharma could make more of its real world evidence

    In 2016, the category is open to medicines that have won or received a commendation at previous UK Prix Galien Awards. ... The introduction of the Real World Evidence Award is an important milestone in the evolution of UK Prix Galien.

  • UK Prix Galien opens for entries UK Prix Galien opens for entries

    Pictured: Novartis pick up the 2014 Innovative Product award. Entries have opened for the 2016 UK Prix Galien Awards, which commend pharmaceutical research and development and celebrate outstanding efforts to improve ... The UK Prix Galien franchise is

  • Novartis' Bexsero triumphs at UK Prix Galien Novartis' Bexsero triumphs at UK Prix Galien

    Rawlins. Novartis' breakthrough meningitis vaccine Bexsero took the top prize at last night's Prix Galien ceremony at the House of Commons in London, picking up the Innovative Product award. ... Meanwhile, the UK Prix Galien's Orphan Drug prize went to

More from news
Approximately 4 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics